Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892266 · ClinicalTrials.gov registry record
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
A clinical trial of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 124
- Enrollment target
- 13
- Study locations
NCT02892266 is a study of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 124 participants. The trial reports 13 study locations across 9 states.
The verdict
NCT02892266, a study of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
- 13
- Study locations
Study Summary
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine. Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Conditions Studied
Interventions
- OTHER Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Study Locations (13)
California
- Ronald Reagan UCLA Medical Center: Pediatric Transplantation - Los Angeles
- Lucile Salter Packard Children's Hospital at Stanford: Pediatric Transplantation - Palo Alto
- UCSF Benioff Children's Hospital: Pediatric Transplantation - San Francisco
Ohio
- Cincinnati Children's Hospital Medical Center: Pediatric Transplantation - Cincinnati
- Nationwide Children's Hospital - Columbus
Texas
- University of Texas Southwestern/Children's Medical Center: Pediatric Transplantation - Dallas
- Texas Children's Hospital: Pediatric Transplantation - Houston
Florida
- University of Miami, Jackson Memorial Hospital: Pediatric Transplantation - Miami
Illinois
- Ann and Robert H. Lurie Children's Hospital of Chicago: Pediatric Transplantation - Chicago
Massachusetts
- Boston Children's Hospital: Pediatric Transplantation - Boston
Missouri
- St. Louis Children's Hospital: Pediatric Transplantation - St Louis
New York
- Columbia University Medical Center: Pediatric Transplantation - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-11-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02892266
The ClinicalTrials.gov registry entry for NCT02892266 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Organ Transplant Recipients appearing as the primary indexed condition, and to 1 intervention - of which Assessment of adherence, mental health, behavioral, quality of life and biological constructs is the first listed.
NCT02892266 reports 13 study locations spanning 9 distinct geographic areas - top geographies include California, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT02892266 about?
NCT02892266 is a clinical study titled "Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients". This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine. Target population: medically stable adolescent ...
What is the current status of trial NCT02892266?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2016-09. Estimated completion is 2018-11-24.
What conditions does trial NCT02892266 study?
This clinical trial studies the following conditions: Solid Organ Transplant Recipients, Parent(s)/Guardian of Referenced Transplant Recipients.
What interventions are being tested in trial NCT02892266?
The interventions under investigation include: Assessment of adherence, mental health, behavioral, quality of life and biological constructs (OTHER).
Who is sponsoring clinical trial NCT02892266?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02892266 being conducted?
This trial has 13 study locations across California, Florida, Illinois, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Solid Organ Transplant Recipients
All registered trials for this condition
Parent(s)/Guardian of Referenced Transplant Recipients
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.